Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Agency Takes On ResMed Sleep Mask Complaint

Executive Summary

The US International Trade Commission has agreed to investigate ResMed’s complaint that a New Zealand company and its American subsidiaries are illegally importing and selling sleep masks that violate ResMed patents.

You may also be interested in...



ResMed Takes CPAP Patent Fight Back To ITC

The continuous positive airway pressure manufacturer lost a 2013 patent case against BMC when its humidifier patent was ruled invalid due to prior art, but it’s now filed a fresh claim asserting a new and more narrowly tailored patent.

ResMed files infringement case against Fisher & Paykel

ResMed has filed a lawsuit against New Zealand company Fisher & Paykel Healthcare alleging that its Aclaim masks infringe patents and other IP rights held by ResMed. ResMed alleges that Auckland-based F&P copied ResMed's proprietary mask technology. F&P refutes the claims.

Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217

The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT123385

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel